RFP Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$307K Buy
+4,722
New +$326K 0.15% 56

Other funds holding XPH

RFP Financial Group's XPH Position: Q3 2026 in Review

RFP Financial Group opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 4,722 shares worth $307K. The stake represents 0.15% of the portfolio and ranks #56 among its holdings.

117 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • RFP Financial Group held 4,722 shares of State Street SPDR S&P Pharmaceuticals ETF worth $307K as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new RFP Financial Group position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.15% of RFP Financial Group's portfolio in Q3 2026, its #56 holding.
  • 117 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on RFP Financial Group's 13F filing for Q3 2026, filed 10 Nov 2026.